Valeant Pharmaceuticals International Business Systems Analyst Salary
The average Valeant Pharmaceuticals International Business Systems Analyst earns an estimated $94,599 annually, which includes an estimated base salary of $86,927 with a $7,672 bonus. Valeant Pharmaceuticals International's Business Systems Analyst compensation is $11,128 more than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Valeant Pharmaceuticals International can range from $55,132 - $170,000.
The Operations Department at Valeant Pharmaceuticals International earns $18,983 more on average than the Admin Department.
Last updated 2 years ago.
- $86,927
- avg. base
- $7,672
- avg. bonus
Business Systems Analyst Salaries at Valeant Pharmaceuticals International
Business Systems Analysts earn $3,442 more than Business Analysts, and $15,470 less than Operations Managers.
Compensation at Valeant Pharmaceuticals International by Department
The Operations Department averages $18,983 more than the Admin Department, and $11,404 less than the Marketing Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Valeant Pharmaceuticals International reported making $89,933, while the average male Business Systems Analyst at similar sized companies reported making $93,781.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to Valeant Pharmaceuticals International reported making $115,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $75,705.
How Business Systems Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Business Systems Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Business Systems Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
